Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer.
Missense mutations in the androgen receptor (AR) contribute to the failure of hormonal therapy for prostate cancer (PCa), but the underlying molecular bases remain uncharacterized. Here, we describe a new AR variant found in a hormone-refractory metastatic PCa, in which threonine 575 in the DNA binding domain, and threonine 877 in the ligand-binding domain, were both replaced by an alanine. Using gene reporter assays, we demonstrate that the T575A mutation weakened transcriptional activity from promoters containing AR-specific responsive elements, while activity from promoters with AR-non-specific elements was enhanced. Data from gel shift experiments revealed a preferential binding of the T575A mutant to AR-non-specific motifs. We demonstrate that the two mutations T575A and T877A cooperate to confer new functional properties on the AR, and that the mutant AR functions simultaneously as a promiscuous AR due to the T877A mutation, and an unfaithful AR due to the T575A mutation.
Monge
A
A
Laboratoire de Cancérologie Expérimentale et de Radiobiologie, EA 3430, Université Louis Pasteur de Strasbourg, IRCAD, BP426, Strasbourg Cedex, 67091, France.
Jagla
M
M
Lapouge
G
G
Sasorith
S
S
Cruchant
M
M
Wurtz
J-M
JM
Jacqmin
D
D
Bergerat
J-P
JP
Céraline
J
J
D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D019556:COS Cells; D002522:Chlorocebus aethiops; D005485:Flutamide / Q000494:pharmacology; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D008297:Male; D009154:Mutation; D011471:Prostatic Neoplasms / Q000235:genetics*; D011944:Receptors, Androgen / Q000235:genetics* / Q000378:metabolism; D020218:Response Elements / Q000235:genetics; D013256:Steroids / Q000494:pharmacology; D013912:Threonine / Q000235:genetics*
D000726:Androgen Antagonists; D011944:Receptors, Androgen; D013256:Steroids; D013912:Threonine; D005485:Flutamide; D008156:Luciferases